Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Use coupon code “MARCH20” for a 20% discount on all items! Valid until 31-03-2025

Site Logo
Site Logo

Royal Mail  express delivery to UK destinations

Regular sales and promotions

Stock updates every 20 minutes!

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

3 in stock

Firm sale: non returnable item
SKU 9780443186776 Categories ,
Select Guide Rating
Overexpression of receptor tyrosine kinases (RTKs) has been implicated in cancer. Increasing evidence suggests that dysregulation of RTKs is reported in many neurodegenerative and psychiatric disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorde...

£121.00

Buy new:

Delivery: UK delivery Only. Usually dispatched in 1-2 working days.

Shipping costs: All shipping costs calculated in the cart or during the checkout process.

Standard service (normally 2-3 working days): 48hr Tracked service.

Premium service (next working day): 24hr Tracked service – signature service included.

Royal mail: 24 & 48hr Tracked: Trackable items weighing up to 20kg are tracked to door and are inclusive of text and email with ‘Leave in Safe Place’ options, but are non-signature services. Examples of service expected: Standard 48hr service – if ordered before 3pm on Thursday then expected delivery would be on Saturday. If Premium 24hr service used, then expected delivery would be Friday.

Signature Service: This service is only available for tracked items.

Leave in Safe Place: This option is available at no additional charge for tracked services.

Description

Product ID:9780443186776
Product Form:Paperback / softback
Country of Manufacture:NL
Title:Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
Authors:Author: Aiman Saad and Professor of Pharmacology and Toxicology, Cairo University, Cairo, Egypt) El-Khatib, Mahmoud Mohamed Khattab, Heba Mohamed, PhD , Egyptian Drug Authority (EDA), Egypt.) Mansour
Page Count:604
Subjects:Diseases and disorders, Diseases & disorders, Neurology and clinical neurophysiology, Psychiatry, Neurology & clinical neurophysiology, Psychiatry
Description:Select Guide Rating
Overexpression of receptor tyrosine kinases (RTKs) has been implicated in cancer. Increasing evidence suggests that dysregulation of RTKs is reported in many neurodegenerative and psychiatric disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders provides a fundamental, pragmatic map of RTKs structure, activation, functions, mechanism of action, gene regulation, and signaling pathways in developing central nervous system (CNS), adult normal CNS, neurodegenerative and psychiatric disorders. Additionally, the structure, function, activation, and therapeutic potential of many growth factors have been covered. Here, international experts in the field offer a comprehensive discussion of results of pre-clinical and clinical studies of repositioning of anti-cancer receptor tyrosine kinase inhibitors (RTKIs) and other promising protein kinase inhibitors in various neurodegenerative disorders including, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis, and psychiatric disorders including, anxiety, depression, alcohol use disorder, and schizophrenia. In addition, the book discusses the obstacles and opportunities for the potential repositioning of kinase inhibitors in neurodegenerative and psychiatric disorders.
Imprint Name:Academic Press Inc
Publisher Name:Elsevier Science Publishing Co Inc
Country of Publication:GB
Publishing Date:2023-06-08